NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel With New Avenova Programs
Portfolio Pulse from Benzinga Newsdesk
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) has announced the launch of two new promotional programs for ophthalmologists and optometrists who help their patients manage the symptoms of chronic dry eye with Avenova-branded products. The Avenova Loyalty Program and Avenova Affiliate Program are designed to increase awareness of the full suite of Avenova products and reward top eyecare professionals.
October 11, 2023 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NovaBay's new promotional programs for Avenova products could potentially increase sales and awareness, which may have a positive impact on the company's stock.
The launch of new promotional programs indicates NovaBay's active efforts to boost sales and increase product awareness. If successful, these programs could lead to increased revenue, which would likely be viewed positively by investors and could lead to an increase in the company's stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100